combination therapies outperforming semaglutide Novo Nordisk's CagriSema Fixed-Dose Combination Delivers Superior HbA1c and Weight Loss in Phase 3 REIMAGINE Trials – Amylin/GLP-1 Dual Therapy Outperforms Semaglutide Monotherapy Semaglutide vs Tirzepatide: Complete Comparison

Research published on Wednesday in the BMJ found that people who stopped taking weight-loss drugs, including GLP-1 medications, are likely to see all the weight-loss and heart health benefits disappear in less than two years

Oral metabolic franchise, a broader portfolio of oral small molecule candidates targeting metabolic disease beyond the lead GLP-1 program Recent Highlights: In May 2026, Structure reported positive end-of-Phase 2 feedback from the FDA for aleniglipron, clearing the way to begin a Phase 3 registrational program for chronic weight management in Q3 2026

L-Carnitine is a naturally occurring compound that helps transport fatty acids into the mitochondria, where they are used to produce energy

We can help guide you through dosing adjustments, cost-saving options, and strategies for managing side effects to ensure a smooth transition

Conclusion TRIUMPH-4's cardiovascular findings extend far beyond a medication that causes weight loss